Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus

The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore grea...

Full description

Saved in:
Bibliographic Details
Main Authors FOSCHINI, FULVIO, ROY, PIERRE, STAGNI, MARCELLO, LUCIANI, GIULIO
Format Patent
LanguageEnglish
Published 21.04.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the treatment of keratoconus.
Bibliography:Application Number: AU20120327916